Järnerot G - Search Results

1

Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties.

Sandberg-Gertzén H, Järnerot G, Kraaz W. Sandberg-Gertzén H, et al. Among authors: jarnerot g. Gastroenterology. 1986 Apr;90(4):1024-30. doi: 10.1016/0016-5085(86)90882-6. Gastroenterology. 1986. PMID: 2868964 Clinical Trial.

2

The thyroid in ulcerative colitis and Crohn's disease. I. Thyroid radioiodide uptake and urinary iodine excretion.

Järnerot G. Järnerot G. Acta Med Scand. 1975 Jan-Feb;197(1-2):77-81. doi: 10.1111/j.0954-6820.1975.tb04881.x. Acta Med Scand. 1975. PMID: 235826

3

Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites.

Järnerot G, Into-Malmberg MB, Esbjörner E. Järnerot G, et al. Scand J Gastroenterol. 1981;16(5):693-7. doi: 10.3109/00365528109182032. Scand J Gastroenterol. 1981. PMID: 6119765

4

Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.

Sandborn WJ, Feagan BG, Marano C, Zhang H, Strauss R, Johanns J, Adedokun OJ, Guzzo C, Colombel JF, Reinisch W, Gibson PR, Collins J, Järnerot G, Rutgeerts P; PURSUIT-Maintenance Study Group. Sandborn WJ, et al. Among authors: jarnerot g. Gastroenterology. 2014 Jan;146(1):96-109.e1. doi: 10.1053/j.gastro.2013.06.010. Epub 2013 Jun 14. Gastroenterology. 2014. PMID: 23770005 Clinical Trial.

5

Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.

Sandborn WJ, Feagan BG, Marano C, Zhang H, Strauss R, Johanns J, Adedokun OJ, Guzzo C, Colombel JF, Reinisch W, Gibson PR, Collins J, Järnerot G, Hibi T, Rutgeerts P; PURSUIT-SC Study Group. Sandborn WJ, et al. Among authors: jarnerot g. Gastroenterology. 2014 Jan;146(1):85-95; quiz e14-5. doi: 10.1053/j.gastro.2013.05.048. Epub 2013 Jun 2. Gastroenterology. 2014. PMID: 23735746 Clinical Trial.

6

Infliximab or cyclosporine for severe ulcerative colitis.

Järnerot G. Järnerot G. Gastroenterology. 2006 Jan;130(1):286; author reply 287. doi: 10.1053/j.gastro.2005.11.037. Gastroenterology. 2006. PMID: 16401502 No abstract available.

7

The Short Health Scale: a valid measure of subjective health in ulcerative colitis.

Hjortswang H, Järnerot G, Curman B, Sandberg-Gertzén H, Tysk C, Blomberg B, Almer S, Ström M. Hjortswang H, et al. Among authors: jarnerot g. Scand J Gastroenterol. 2006 Oct;41(10):1196-203. doi: 10.1080/00365520600610618. Scand J Gastroenterol. 2006. PMID: 16990205

8

The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis.

Hjortswang H, Järnerot G, Curman B, Sandberg-Gertzén H, Tysk C, Blomberg B, Almer S, Ström M. Hjortswang H, et al. Among authors: jarnerot g. Eur J Gastroenterol Hepatol. 2003 Sep;15(9):1011-20. doi: 10.1097/00042737-200309000-00012. Eur J Gastroenterol Hepatol. 2003. PMID: 12923375

9

Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era.

Gustavsson A, Halfvarson J, Magnuson A, Sandberg-Gertzén H, Tysk C, Järnerot G. Gustavsson A, et al. Among authors: jarnerot g. Am J Gastroenterol. 2007 Nov;102(11):2513-9. doi: 10.1111/j.1572-0241.2007.01435.x. Epub 2006 Aug 4. Am J Gastroenterol. 2007. PMID: 17680849

10

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C, Vilien M, Ström M, Danielsson A, Verbaan H, Hellström PM, Magnuson A, Curman B. Järnerot G, et al. Gastroenterology. 2005 Jun;128(7):1805-11. doi: 10.1053/j.gastro.2005.03.003. Gastroenterology. 2005. PMID: 15940615 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results